Chronic spontaneous urticaria exacerbation in a patient with COVID-19: rapid and excellent response to omalizumab

Int J Dermatol. 2020 Oct;59(10):1294-1295. doi: 10.1111/ijd.15134. Epub 2020 Aug 17.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-Allergic Agents / administration & dosage*
  • COVID-19 / complications
  • COVID-19 / diagnosis
  • COVID-19 / immunology*
  • COVID-19 / virology
  • Chronic Urticaria / drug therapy*
  • Chronic Urticaria / immunology
  • Female
  • Humans
  • Injections, Subcutaneous
  • Lung / diagnostic imaging
  • Middle Aged
  • Omalizumab / administration & dosage*
  • SARS-CoV-2 / immunology
  • SARS-CoV-2 / isolation & purification
  • Symptom Flare Up*
  • Time Factors
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Anti-Allergic Agents
  • Omalizumab